Evidence map›Paper›PMID 41868379›Full record

ArticleFrontiers in microbiology2026

Dissemination of a

Dandan Dong, Luze Zou, Zhenzhen Liu, Nan Jia, Yanfei Liu, Hui Zhao, Yuanqi Zhu

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Dandan Dong *Department of Clinical Laboratory, The Affiliated Hospital of Qingdao University, Qingdao, China.
Luze Zou *Department of Clinical Laboratory, The Affiliated Hospital of Qingdao University, Qingdao, China.
Zhenzhen LiuDepartment of Clinical Laboratory, The Affiliated Hospital of Qingdao University, Qingdao, China.
Nan JiaDepartment of Clinical Laboratory, The Affiliated Hospital of Qingdao University, Qingdao, China.
Yanfei LiuDepartment of Clinical Laboratory, The Affiliated Hospital of Qingdao University, Qingdao, China.
Hui ZhaoDepartment of Clinical Laboratory, The Affiliated Hospital of Qingdao University, Qingdao, China.
Yuanqi ZhuDepartment of Clinical Laboratory, The Affiliated Hospital of Qingdao University, Qingdao, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Carbapenem-resistant Methods: We characterized 13 clinical isolates (10 CRKP [TJ01-TJ10] and 3 CRKO [TJ11-TJ13]) recovered from preterm infants between September 2013 and January 2014. The whole genome sequencing of strains (CRKP TJ03 and CRKO TJ11) was performed using MiSeq and MinION platforms, while the plasmids pNDM-TJ03 and pNDM-TJ11 were derived from the above-mentioned strains. Antimicrobial susceptibility testing, plasmid conjugal transfer, and other experiments were conducted. Results: PFGE revealed clonal dissemination of CRKP ST30 and CRKO ST2 strains. This represents both the first documented neonatal outbreak caused by CRKP ST30 globally and the first report of CRKO ST2 in China, demonstrating novel transmission patterns of these high-risk clones in neonatal settings. All isolates carried Conclusions: This study demonstrates that there may have been intra-strain and inter-species spread of a

Indexed as

BlaNDM-1Klebsiella oxytocaKlebsiella pneumoniaeneonatesoutbreakplasmid

Identifiers

PMID41868379
PMCPMC13003566

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.